For their tiny medication delivery robots, Bionaut Labs receives $43.2 million techgadgetcentral.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from techgadgetcentral.com Daily Mail and Mail on Sunday newspapers.
Los Angeles-based Bionaut Labs, a company developing microscale robots for treating central nervous system (CNS) diseases and disorders, said this week that it has raised $43.2M in a Series B funding.
The funds raised will be used to advance clinical development of the company’s lead programs against malignant glioma brain tumors and Dandy-Walker Syndrome.
Bionaut Raises $43 Million to Advance Micro-Robotic Tech globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.